Dark

BOLD
Boundless Bio, Inc. Common Stock
stock NASDAQ

At Close

Oct 2, 2026 3:59:51 PM EDT

2.63USD+1.544%(+0.04)156,529

0.00Bid 0.00Ask 0.00Spread

Pre-market

Oct 1, 2026 8:04:30 AM EDT

2.48USD-4.247%(-0.11)0

After-hours

Sep 29, 2026 4:25:30 PM EDT

2.60USD+1.563%(+0.04)0

Overview HistoricalExchangesShortsMore

open chart

Market Cap

59.37M

Headquarters

CA, USA

Industry

Biotechnology

Next Earnings

Nov 4, 2026 (31d)

PDLI PIRS XLV

BOLD Stats

Avg. Vol. 10 Day

186,258

Avg. Vol. 30 Day

126,231

Employees

152

Market Cap

59,372,241

Shares Out.

22,747,985

On/Off Exchange

63%/37%

6 Month Beta

-0.63

1 Year Beta

-0.05

2 Year Beta

0.73

3 Year Beta

0.95

52 Week Low

0.96

52 Week High

3.16

SMA50

2.76

SMA200

1.79

1 Week

-1.88%

1 Month

-9.06%

3 Month

+4.40%

6 Month

+141.67%

1 Year

+112.20%

2 Year

-16.61%

5 Year

-95.65%

Profile

Audentes Therapeutics Inc is a biotechnology company. It is engaged in developing and commercializing gene therapy products for patients suffering from serious, life-threatening rare diseases caused by single gene defects.

BOLD Stock Summary

Boundless Bio, Inc. Common Stock (NASDAQ:BOLD) stock price today is $2.63, and today's volume is 156,529. BOLD is up 1.544% today. The 30 day average volume is 126,231. BOLD market cap is 59.37M with 22,747,985 shares outstanding.